A pharmacovigilance study to determine risk of mortality in male and female patients with Alzheimer's disease using Rivastigmine

A pharmacovigilance study to determine risk of mortality in male and female patients with Alzheimer's disease using Rivastigmine

This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2023.

Dades bibliogràfiques
Autor principal:	Shehab, Habibul Mohsin
Altres autors:	Yasmin, Hasina
Format:	Thesis
Idioma:	English
Publicat:	Brac University 2024
Matèries:	Pharmacovigilance Rivastigmine Alzheimer's disease Dementia Pharmacoepidemiology. Mortality. Alzheimer's disease.
Accés en línia:	http://hdl.handle.net/10361/22683

Ítems similars

Gender-specific Rhabdomyolysis risk in Alzheimer’s disease patients receiving memantine: a pharmacovigilance study
per: Tabassum, Nadira
Publicat: (2024)

Signal detection of rhabdomyolysis and death for rivastigmine: a pharmacovigilance study
per: Mahee, Sadique Abdal
Publicat: (2024)

Efficacy of Rivastigmine in Alzheimer’s disease- A structured seview
per: Alim, Abdul
Publicat: (2023)

Signal detection of Rhabdomyolysis and death for galantamine: a pharmacovigilance study
per: Karmaker, Swastika
Publicat: (2024)

A pharmacovigilance study on Donepezil: signal detection of rhabdomyolysis and death
per: Jahan, Nusrat
Publicat: (2023)

Comprehensive review on importance, challenges and future prospects of nanotechnology and combination therapy for Alzheimer’s disease
per: Ishrat, Nowshin
Publicat: (2024)

A pharmacovigilance study on Memantine: signal detection of Rhabdomyolysis and death
per: Bakar, Osama Bin Abu
Publicat: (2024)

Knowledge of Alzheimer’s disease and its relationship with attitude towards genetic testing for the disease: a survey of the general public in Bangladesh
per: Chowdhury, Sariya Uzrat
Publicat: (2022)

Role of protein’s and future treatment options for Alzheimer’s Disease
per: Islam, Md. Irfath
Publicat: (2023)

Review on: Contribution of nutrients to retard the progression of Alzheimer’s disease
per: Saha, Bithi Rani
Publicat: (2023)

Alzheimer's disease and marriage : an intimate account /
per: Wright, Lore K.
Publicat: (1993)

Progress of finding latent therapeutic activity of vaccine for Alzheimer’s disease
per: Hassan, Md. Muhtaz
Publicat: (2020)

Glymphatic system: a pathway for managing endogenous metabolites in CNS
per: Tasneem, Sadia
Publicat: (2021)

Bio-similar drug development and accessible drugs in the market for the treatment of Alzheimer's Disease: Current status
per: Tamanna, Mst. Taskia
Publicat: (2023)

Emerging therapies of Alzheimer’s disease: a comprehensive review
per: Tasin, Md Abtahi
Publicat: (2023)

Biomarkers of Alzheimer’s disease: a hope for early diagnosis
per: Aziz, Farhin
Publicat: (2019)

An ambient assisted living system for Alzheimer’s patients
per: Abedin, Minhajul, et al.
Publicat: (2023)

Prospective detection methods for Tau protein: an important biomarker for Alzheimer’s disease
per: Afra, Sumaiya
Publicat: (2022)

Marine compounds in the treatment of Alzheimer’s disease
per: Parveen, Sanjana
Publicat: (2022)

Application of microRNA (miRNA) in Alzheimer’s Disease (AD)
per: Halim, Rabea
Publicat: (2022)

Exploring the role of programmed cell death protein 1 in alzheimer’s disease associated autoimmunity
per: Aana, Afsara Sumon
Publicat: (2021)

Exploring Alzheimer's disease prediction with XAI in various neural network models
per: Rahman, Quazi Ashikur, et al.
Publicat: (2022)

Epigenetic dysregulation in neurodegenerative diseases and potential treatment
per: Mostofa, Golam
Publicat: (2022)

Gene editing for neurodegenerative diseases-A review
per: Sharna, Anika Islam
Publicat: (2023)

A review on adult neurogenesis in Alzheimer’s disease
per: Akter, Moriam
Publicat: (2022)

Potential treatments for epigenetic dysregulation in neurological diseases
per: Zaman, Rubaiyat
Publicat: (2024)

A review of comparison on efficacy, safety and cost effectiveness of cholinesterase inhibitors, NMDA antagonists and combination therapy in the treatment of Alzheimer’s disease
per: Haque, Mushfiqul
Publicat: (2019)

Federated GAN based biomedical image augmentation and classification for Alzheimer’s disease
per: Roy, Aditya, et al.
Publicat: (2023)

Investigating the link between Cardiovascular diseases and neurodegenerative disorders
per: Dey, Manashi
Publicat: (2024)

An efficient deep learning approach for detecting Alzheimer’s disease using brain images
per: Sani, Mehedi Hasan, et al.
Publicat: (2022)

Anti-alzheimer and antioxidant activity of celastrus paniculatus seed
per: Alam, Badrul, et al.
Publicat: (2016)

Role of circular RNA in neurological disease
per: Salsabil, Labiba
Publicat: (2024)

Design and evaluation of convolutional neural network for detection of Alzheimer’s disease using MRI data
per: Mahbub, Riasat, et al.
Publicat: (2022)

Skeleton /
per: Parkin, Peter

A review on interrelation among post-authorisation study, regulatory action and pharmacogenetics in pharmacovigilance
per: Nusrat, Tanzina
Publicat: (2019)

হার্ট, ব্লাড, ফুড /
per: কাসেম, এম এ

Antihypertensive drugs and risk of cancer: A pharmacovigilance study
per: Rahman, Ahadina
Publicat: (2018)

Management of Diabetes patients during COVID-19
per: Pantho, G. M. Golam Mehebub
Publicat: (2021)

Pharmacoepidemiology and pharmacovigilance : synergistic tools to better Investigate drug safety /
per: Nour, Sabrina
Publicat: (2019)

Detection of alzheimer's disease using deep learning
per: Hasan, Mahmudul, et al.
Publicat: (2021)